找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Oral Antidiabetics; Jochen Kuhlmann,Walter Puls Book 1996 Springer-Verlag Berlin Heidelberg 1996 Antidiabetics.Biguanides.Diabetes.Diabete

[復(fù)制鏈接]
樓主: Inspection
31#
發(fā)表于 2025-3-26 21:47:02 | 只看該作者
Sulfonylureas: Physico-chemical Properties, Analytical Methods of Determination and Bioavailabilitytic drugs include acetohexamide, acetylcarbutamide, carboxytolbutamide, carbutamide, chlorpropamide, glibenclamide, glibornuride, gliclazide, glimepiride, glipizide, gliquidone, glisoxepide, metahexamide, tolazamide and tolbutamide. The structural formulas of some of the important antidiabetic agents are given in Fig. 1.
32#
發(fā)表于 2025-3-27 02:48:17 | 只看該作者
33#
發(fā)表于 2025-3-27 06:09:17 | 只看該作者
Clinical Pharmacology of Sulfonylureasion of insulin secretion. Sulfonylureas bind to receptor-like structures on the B cell, which may be closely linked to or be part of the potassium channels (. et al. 1987; . et al. 1988; . et al. 1990). The binding capacity of different sulfonylureas reflects their ability to stimulate insulin secretion.
34#
發(fā)表于 2025-3-27 13:26:43 | 只看該作者
35#
發(fā)表于 2025-3-27 15:33:44 | 只看該作者
36#
發(fā)表于 2025-3-27 18:21:56 | 只看該作者
Chemistry and Structure-Activity Relationships of Glucosidase Inhibitorse rational design of a lead compound, when the biochemical mechanism and the structure of the enzyme are well known. In the late 1960s, when we started to look for such potent and selective inhibitors, we had to choose the random screening approach, relying mainly on testing of extracts of the culture broths of microorganisms.
37#
發(fā)表于 2025-3-28 00:55:02 | 只看該作者
0171-2004 -threatening disease. This attitude needs to be changed because the complications asso- ciated with the adult form of diabetes affect almost every organ system. The high morbidity and mortality of non-insulin-dependent diabetes mellitus (NIDDM) suggest that current treatment strategies are unsatisfa
38#
發(fā)表于 2025-3-28 03:16:18 | 只看該作者
39#
發(fā)表于 2025-3-28 06:27:52 | 只看該作者
40#
發(fā)表于 2025-3-28 13:06:16 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-11 04:24
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
富蕴县| 邛崃市| 出国| 遵义县| 平山县| 邵武市| 古田县| 安塞县| 五大连池市| 双辽市| 临清市| 长顺县| 江津市| 巫溪县| 边坝县| 黑水县| 安西县| 宾川县| 庄浪县| 衡东县| 治县。| 乐平市| 新绛县| 万山特区| 饶河县| 望奎县| 鄂尔多斯市| 张北县| 宽城| 平凉市| 肃北| 喜德县| 公安县| 芜湖市| 楚雄市| 团风县| 疏勒县| 新龙县| 巴林右旗| 凌云县| 漳浦县|